Stem Cell Approaches in Neurology and Psychiatry
Published August 19, 2010
2nd biennial report
An industry insider report on innovative research and development in stem cell technology for the central nervous system
- Analyzes the scientific approaches and challenges to utilizing stem cells in the CNS
- Discusses trends and drivers including funding and regulatory issues
- Reveals promising treatment indications and pipelines
- Details cell therapies for Parkinson's, SCI, stroke, Alzheimer's, ALS, MS, retina and more
- Examines business models leveraging the promise of stem cells
- Sheds light on investment opportunities and risks
- Provides in-depth profiles of trendsetters and trailblazers
Table of Contents
Over 125 Companies Included
|
25 Trendsetters for 2011:
- Advanced Cell Technology
- ArunA Biomedical
- Athersys
- Beike Biotechnology Company
- BrainCells, Inc.
- BrainStorm Cell Therapeutics
- California Stem Cell
- Cell Cure Neurosciences
- CellMed AG
- DaVinci Biosciences
- Geron Corporation
- International Stem Cell Corporation
- iPierian
- NeuralStem
- NeuroGeneration
- NeuroNova AB
- NsGene A/S
- Pfizer Regenerative Medicine
- Q Therapeutics
- ReNeuron Group
- RhinoCyte
- SanBio
- StemCell Technologies
- StemCells, Inc.
- Stemedica
|
|
|
